Further medicines added to list that cannot be parallel exported from the UK

33 new medicines have been added to the parallel export list, including respiratory agents (e.g. aclidinium; tiotropium), cardiovascular medicines (digoxin; metoprolol; dabigatran), diabetes medicines (dapagliflozin), and analgesics (buprenorphine; ibuprofen), among others.

Medicines and Healthcare products Regulatory Agency